Danvers, MA, United States of America

Paul Higgins

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Ucb S.a., Ucb, S.a./n.v.. Active years: 2004-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Higgins. Retrieved from https://idiyas.com/inventor/paul-higgins-rnz3428t

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2004-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Paul Higgins: Innovator in Pharmaceutical Compositions

Introduction

Paul Higgins is a notable inventor based in Danvers, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on pyrrolidinone derivatives. With a total of 2 patents, Higgins has established himself as a key figure in the development of novel compounds aimed at treating various medical conditions.

Latest Patents

Higgins' latest patents focus on pyrrolidinone derivatives. The present invention provides pharmaceutical compositions and novel compounds useful in the treatment of conditions mediated by CCR2, MCP-1, or the interaction thereof. The compounds of the present invention are pyrrolidinones and pyrrolidine-thiones. This work highlights his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Paul Higgins has worked with prominent companies in the pharmaceutical industry, including UCB, S.A./N.V. and UCB S.A. His experience in these organizations has allowed him to collaborate with other talented professionals and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Dong Zou and Olivier Dasse. Their collaborative efforts have further enhanced the impact of Higgins' inventions in the pharmaceutical sector.

Conclusion

In summary, Paul Higgins is a distinguished inventor whose work on pyrrolidinone derivatives has the potential to transform pharmaceutical treatments. His contributions reflect a deep commitment to innovation and improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…